Accessibility Menu
Genus Plc logo

Genus Plc(LSE) GNS

Market Cap£1.50BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1998)+2,459%
5 Year-61%
1 Year-10%
1 Month+9%
£22.92
+1.60%
+0.36Today
Genus Plc last closing stock price
MetricPriceDate
Last closeGBX 2,294.002026-08-13
Genus Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.35%GBX 2,302.002026-08-06
1 month+8.72%GBX 2,110.002026-07-14
3 month-4.5%GBX 2,402.002026-05-15
Year to date-11.6%GBX 2,595.002025-12-31
1 year-9.69%GBX 2,540.002025-08-13
3 year-1.88%GBX 2,338.002023-08-14
5 year-60.65%GBX 5,830.002021-08-13
Since inception+2,458.61%GBX 0.881998-01-30

Genus Plc Financials at a Glance

Market Cap

£1.50BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£1.34B

Net Income (TTM)

£43.50M

EPS (TTM)

£0.71

P/E Ratio

31.36

Dividend

£0.33

Beta (Volatility)

0.01 (Low)

Price

£22.92

Volume

6,099

Open

£22.00

Previous Close

£22.56

Daily Range

£22.00 - £22.98

52-Week Range

£19.43 - £32.29

Estimated Earnings Date

Sep 10, 2026

GNS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Genus Plc

Genus plc is a global leader in animal genetics, specializing in the breeding of livestock to enhance productivity and sustainability. The company operates across multiple regions, including North America, Europe, and Asia, and is committed to advancing agricultural practices through innovative genetic solutions.

Products and Services
  • Breeding stock for pigs, including sows, boars, and semen
  • Genetic solutions for cattle, offering bull semen and embryos
  • Specialized technical services, such as semen sexing and reproductive solutions
Growth Outlook
  • Strategic collaboration with Beijing Capital Agribusiness for PRRSV-resistant pigs
  • Expansion into emerging markets to meet growing protein demand
  • Investment in R&D to enhance genetic technologies and product offerings
Financial Highlights
  • Recent quarterly revenue of £335.6 million, reflecting strong market demand
  • Net income of £29.8 million, showcasing profitability and operational efficiency
  • TTM gross profit margin of 93.56%, indicating robust pricing power
Genus plc has established itself as a pivotal player in the biotechnology sector, focusing on animal genetics to improve livestock quality and production efficiency. The company's diverse product offerings cater to the needs of farmers, enhancing their ability to produce high-quality meat and dairy products. The growth outlook for Genus is promising, driven by strategic partnerships and a commitment to innovation. The collaboration with Beijing Capital Agribusiness highlights the company's focus on addressing specific challenges in livestock production, such as disease resistance. Additionally, the expansion into emerging markets presents significant opportunities for revenue growth, as global protein demand continues to rise. Financially, Genus has demonstrated resilience, with a recent quarterly revenue of £335.6 million and a net income of £29.8 million. The impressive gross profit margin of 93.56% underscores the company's strong market position and pricing strategy. With a focus on research and development, Genus is well-positioned to capitalize on future growth opportunities in the animal genetics industry.
AI Generated • Aug 4, 2026

Industry

Biotechnology

Sector

Health Care

Employees

3,307

CEO

Jorgen Kokke

Website

www.genusplc.com

Headquarters

Basingstoke, HM RG21 4DZ, GB

GNS Financials

Key Financial Metrics (TTM)

Gross Margin

100.07%

Operating Margin

9.78%

Net Income Margin

7.07%

Return on Equity

9.70%

Return on Capital

5.72%

Return on Assets

5.16%

Earnings Yield

3.19%

Dividend Yield

1.46%

Payout Ratio

44.42%

Stock Overview

Market Cap

£1.50BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

66.42M

Volume

6.10K

Avg. Volume

216.91K

Financials (TTM)

Gross Profit

£1.32B

Operating Income

£63.30M

EBITDA

£157.50M

Operating Cash Flow

£120.00M

Capital Expenditure

-£24.50M

Free Cash Flow

£95.50M

Cash & ST Invst.

£43.40M

Total Debt

£260.70M

Genus Plc Performance Analysis

Genus Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30GBP 593,400,000N/A
20232023-06-30GBP 689,700,00016.2%
20242024-06-30GBP 668,800,000-3.0%
20252025-06-30GBP 672,800,0000.6%
Genus Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-300.5%
Q22024-12-310.4%
Q42025-06-30N/A
Q22025-12-31-0.2%
Genus Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30GBP 0.62N/A
20232023-06-30GBP 0.50-18.9%
20242024-06-30GBP 0.12-76.3%
20252025-06-30GBP 0.29141.9%
Genus Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30-142.3%
Q22024-12-31128.5%
Q42025-06-301020.3%
Q22025-12-3163.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

£335.60M

+0.6%

Gross Profit

£314.00M

-5.9%

Gross Margin

93.56%

N/A

Market Cap

£1.50BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£469.70K

N/A

Employees

3,190

N/A

Net Income

£29.80M

+120.7%

EBITDA

£61.10M

+39.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

£43.40M

+3.3%

Total Debt

£260.70M

-10.7%

Accounts Receivable

£124.50M

+11.8%

Inventory

£74.20M

-23.2%

Long Term Debt

£246.10M

-10.1%

Short Term Debt

£14.60M

-21.1%

Return on Assets

5.16%

N/A

Return on Invested Capital

8.35%

N/A

Free Cash Flow

£17.60M

+551.3%

Operating Cash Flow

£22.90M

+118.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HCM.LHUTCHMED (China) Limited
£1.80-0.83%
ONT.LOxford Nanopore Technologies plc
£1.28+0.63%
SPI.LSpire Healthcare Group plc
£2.32+0.65%
OXB.LOxford Biomedica plc
£4.96+0.61%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$9.77+0.00%
NOKNokia
$10.32+0.09%
SPCXSpace Exploration Technologies
$146.15+0.10%
SMCISuper Micro Computer
$37.61+0.19%

Questions About GNS

What is the current price of Genus Plc?

Genus Plc is trading at £22.92 per share.

What is the 52-week range for Genus Plc?

Over the past 52 weeks, Genus Plc has traded between £19.43 and £32.29.

How much debt does Genus Plc have?

As of the most recent reporting period, Genus Plc reported total debt of £265.90M.

How much cash does Genus Plc have on hand?

Genus Plc reported £48.00M in cash and cash equivalents in its most recent financial results.

What is Genus Plc’s dividend yield?

Genus Plc currently has a dividend yield of 1.46%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services